Table 2.
Crude hazard rate ratios in adults aged 15–59 pre- and post-ART roll-out and HIV status for men
Men – HIV negative | Men – HIV positive | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Death | Person-years per 1000 | Death rate | Crude RR | 95% CI | P-value | Death | Person-years per 1000 | Death rate | Crude RR | 95% CI | P-value | |
ART period | ||||||||||||
Pre-0–5 years | 62 | 13.71 | 4.52 | 1 | 63 | 0.89 | 70.77 | 1 | ||||
Post-1st period | 87 | 13.11 | 6.64 | 1.47 | (1.06–2.03) | 0.021 | 43 | 0.79 | 54.48 | 0.77 | (0.52–1.13) | 0.186 |
Age grouped | ||||||||||||
15–29 | ||||||||||||
Pre-0–5 years | 10 | 7.38 | 1.35 | 1 | 10 | 0.31 | 31.96 | 1 | ||||
Post-1st period | 26 | 7.26 | 3.58 | 2.64 | (1.27–5.48) | 0.009 | 7 | 0.22 | 31.92 | 1.00 | (0.38–2.62) | 0.998 |
30–44 | ||||||||||||
Pre-0–5 years | 23 | 4.26 | 5.4 | 1 | 30 | 0.42 | 71.49 | 1 | ||||
Post-1st Period | 30 | 3.6 | 8.33 | 1.54 | (0.90–2.65) | 0.118 | 24 | 0.39 | 61.32 | 0.86 | (0.50–1.47) | 0.575 |
45–59 | ||||||||||||
Pre-0–5 years | 29 | 2.07 | 13.99 | 1 | 23 | 0.16 | 145.9 | 1 | ||||
Post-1st period | 31 | 2.24 | 13.83 | 0.99 | (0.60–1.64) | 0.964 | 12 | 0.18 | 67.19 | 0.46 | (0.23–0.93) | 0.029 |
Area of residence | ||||||||||||
Rural | ||||||||||||
Pre-0–5 years | 35 | 8.93 | 3.92 | 1 | 30 | 0.47 | 64.01 | 1 | ||||
Post-1st period | 58 | 7.95 | 7.3 | 1.86 | (1.22–2.83) | 0.004 | 23 | 0.43 | 53.54 | 0.84 | (0.49–1.44) | 0.519 |
Urban | ||||||||||||
Pre-0–5 years | 19 | 2.57 | 7.4 | 1 | 14 | 0.2 | 68.48 | 1 | ||||
Post-1st period | 14 | 2.62 | 5.35 | 0.72 | (0.36–1.44) | 0.356 | 10 | 0.18 | 54.94 | 0.80 | (0.36–1.81) | 0.595 |
Roadside | ||||||||||||
Pre-0–5 years | 8 | 2.22 | 3.61 | 1 | 19 | 0.22 | 87.53 | 1 | ||||
Post-1st period | 15 | 2.54 | 5.91 | 1.64 | (0.69–3.86) | 0.260 | 10 | 0.18 | 56.28 | 0.64 | (0.30–1.38) | 0.258 |
ART, antiretroviral therapy.